๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Serum carbonic anhydrase III in myotonic dystrophy

โœ Scribed by Dr. Kenji Mokuno; Dr. Shigeo Riku; Dr. Yukihiko Matsuoka; Kanefusa Kato

Publisher
John Wiley and Sons
Year
1986
Tongue
English
Weight
271 KB
Volume
9
Category
Article
ISSN
0148-639X

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Evaluation of carrier detection of Duche
Evaluation of carrier detection of Duchenne muscular dystrophy using carbonic anhydrase III and creatine kinase
โœ Heath, R. ;Carter, N. D. ;Jeffery, S. ;Edwards, R. J. ;Watts, D. C. ;Watts, R. L ๐Ÿ“‚ Article ๐Ÿ“… 1985 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 308 KB ๐Ÿ‘ 2 views

Carbonic anhydrase III (CAIII) and creatine kinase (CK) were measured in plasma samples from a series of females at-risk as carriers of Duchenne muscular dystrophy and compared with control groups. Both plasma CAIII and CK levels were raised in a proportion of carriers. Although measurement of CAIII

Carbonic anhydrase III promotes transfor
Carbonic anhydrase III promotes transformation and invasion capability in hepatoma cells through FAK signaling pathway
โœ Huei-Yue Dai; Chih-Chen Hong; San-Chi Liang; Ming-De Yan; Gi-Ming Lai; Ann-Lii C ๐Ÿ“‚ Article ๐Ÿ“… 2008 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 203 KB

## Abstract Carbonic anhydrase III (CAIII) is distinguished from the other members of the CA family by low carbon dioxide hydratase activity, resistance to the CA inhibitor acetazolamide, and a predominant expression in the liver of males. In this report the effects of CAIII expression on liver can